These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24621251)

  • 1. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of mother-to-child transmission of HIV: antiretroviral strategies.
    Read JS
    Clin Perinatol; 2010 Dec; 37(4):765-76, viii. PubMed ID: 21078449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing HIV infection: pre-exposure and postexposure prophylaxis.
    Doblecki-Lewis S; Kolber MA
    IUBMB Life; 2014 Jul; 66(7):453-61. PubMed ID: 24975125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV treatment and prevention 2019: current standards of care.
    Phanuphak N; Gulick RM
    Curr Opin HIV AIDS; 2020 Jan; 15(1):4-12. PubMed ID: 31658110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
    Hankins CA; Dybul MR
    Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels.
    Hoffmann CJ; Gallant JE
    Infect Dis Clin North Am; 2014 Dec; 28(4):549-61. PubMed ID: 25287588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
    Celum CL; Robinson NJ; Cohen MS
    J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
    Supervie V
    Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral drugs for pre-exposure prophylaxis of HIV infection.
    Fernández-Montero JV; Barreiro P; Del Romero J; Soriano V
    AIDS Rev; 2012; 14(1):54-61. PubMed ID: 22297504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV exposure through contact with body fluids.
    Prescrire Int; 2012 Apr; 21(126):100-1, 103-5. PubMed ID: 22515138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current use of antiretroviral treatment.
    Bailey AC; Fisher M
    Br Med Bull; 2008; 87():175-92. PubMed ID: 18757468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning and doing: operational research and access to HIV treatment in Africa.
    Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP
    AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-1 mother-to-child transmission, post-test counselling, and antiretroviral prophylaxis in Northern Viet Nam: a prospective observational study.
    Ha TT; Anh NM; Bao NH; Tuan PL; Caridha R; Gaseitsiwe S; Hien NT; Cam PD; Ehrnst A
    Scand J Infect Dis; 2012 Nov; 44(11):866-73. PubMed ID: 22803820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postexposure prophylaxis after sexual exposure to HIV.
    Roland ME
    Curr Opin Infect Dis; 2007 Feb; 20(1):39-46. PubMed ID: 17197880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What's new in HIV/AIDS: Some selected topics].
    Vu DL; Daou S; Ambrosioni J; Calmy A
    Rev Med Suisse; 2013 Jan; 9(369):150-5. PubMed ID: 23409658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Considerations in the transgender population regarding HIV infection, antiretroviral therapy, pre-exposure prophylaxis (PreP) and interaction with gender reaffirmation treatment].
    Zapata-Pizarro A; Muena-Bugueño C; Quiroz-Nilo S; Serri-Venegas M; Usedo-López P
    Rev Chilena Infectol; 2022 Apr; 39(2):149-156. PubMed ID: 35856987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.